Natural killers join the fight against cancer-Reference-Cited by-同舟云学术

Natural killers join the fight against cancer

Published:2018-03-30 Issue:6383 Volume:359 Page:1460-1461
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Cerwenka Adelheid¹,Lanier Lewis L.²

Affiliation:

1. Centre for Biomedicine and Medical Technology (CBTM) and European Center for Angioscience (ECAS), Heidelberg University, Medical Faculty Mannheim, Ludolf-Krehl-Strasse 13–17, D-68167 Mannheim, Germany.

2. Department of Microbiology and Immunology and Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94143, USA.

Abstract

An antibody overcomes cancer cell immune evasion and activates natural killer cells

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference15 articles.

1. Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity

2. Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA

3. An Activating Immunoreceptor Complex Formed by NKG2D and DAP10

4. NKG2D Receptor and Its Ligands in Host Defense

5. A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD36: The Bridge between Lipids and Tumors;Molecules;2024-01-21

2. NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer;Cancer Discovery;2024-01-09

3. Developing and validating the model of tumor-infiltrating immune cell to predict survival in patients receiving radiation therapy for head and neck squamous cell carcinoma;Translational Cancer Research;2024-01

4. Recent advances in microfluidic cell separation to enable centrifugationfree, low extracorporeal volume leukapheresis in pediatric patients;BLOOD TRANSFUS-ITALY;2023

5. Rapid, label‐free enrichment of lymphocytes in a closed system using a flow‐through microfluidic device;Bioengineering & Translational Medicine;2023-09-25